In Health Technology Assessment (HTA), the decision threshold for cost-effectiveness in India, as recommended by ICER (Incremental Cost-Effectiveness Ratio), is approximately:
- A One times India's per-capita GDP per DALY averted ✓
- B USD 100 per QALY gained
- C USD 150 per DALY averted regardless of disease
- D Three times India's per-capita GDP per QALY gained
Explanation
WHO's CHOICE (Choosing Interventions that are Cost-Effective) program recommended thresholds of 1×GDP/capita per DALY averted as 'very cost-effective' and 3×GDP/capita as 'cost-effective.' India's HTA secretariat (HTAIn) has adopted approximately 1-1.5 times India's per-capita GDP (~USD 2,000-3,000) as the willingness-to-pay threshold per DALY averted for public health interventions. This threshold guides decisions on inclusion in PM-JAY and government health programs. The choice of DALY (disability-adjusted life year) rather than QALY (quality-adjusted life year) is more common in Indian and LMIC public health planning.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.